Biologics Manufacturing Asia 2026

Mar 11, 2026 - Mar 12, 2026

Sands Expo & Convention Centre, Singapore

Booth：#50a

Overview

The 13th Annual Biologics Manufacturing Asia 2026 is Asia’s premier bioprocessing-focused conference, providing a dedicated platform for regional biopharmaceutical industry stakeholders to network, explore strategic collaborations, and gain insights into the latest manufacturing technologies and advancements.

This year’s agenda is designed to highlight success stories from Asia’s leading biopharma companies while incorporating technical expertise from global biopharma leaders, top pharmaceutical companies, and regulators. Key topics will include cutting-edge manufacturing technologies such as single-use systems and end-to-end continuous processing, challenges and opportunities in biomanufacturing, advancements in upstream process development, cost optimization and timeline reduction in downstream processing, analytical characterization strategies, facility design and scale-up, emerging biologics manufacturing technologies, regulatory updates, and novel biologics modalities.

Co-hosted with BMA 2026, the ADC Asia Congress 2026 emerges as a pivotal gathering in the rapidly evolving Antibody Drug Conjugate industry, where Asia is establishing itself as the epicenter of next-generation ADC development. The congress will unite 40+ industry experts and 300+ attendees from Singapore, China, Japan, South Korea, Australia, and the broader Asia-Pacific region to explore technological innovations, clinical developments, and strategic collaborations in ADC advancement. The event, co-located with several other prestigious biologics conferences, will address critical industry challenges including high development costs and manufacturing complexities, while showcasing breakthrough technologies, real-world applications, and poster presentations highlighting the latest R&D developments. This comprehensive platform reflects the industry's response to increasing global cancer rates and the growing demand for advanced therapeutic options, supported by rising investments and FDA approvals.

Come and find the ACRO Llama at our booth #50a!